Phenyl ureas of creatinine as mGluR5 antagonists. A structure–activity relationship study of fenobam analogues

Structure–activity relationship of the mGluR5 antagonist fenobam is reported. Fenobam ( 1) was developed by McNeil Laboratories as an anxiolytic agent with an unknown molecular target in the late 1970s. In a recent publication, it was revealed that fenobam is a non-competitive mGluR5 antagonist. Her...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters Vol. 16; no. 5; pp. 1142 - 1145
Main Authors: Wållberg, Andreas, Nilsson, Karolina, Österlund, Krister, Peterson, Alecia, Elg, Susanne, Raboisson, Patrick, Bauer, Udo, Hammerland, Lance G., Mattsson, Jan P.
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 01-03-2006
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Structure–activity relationship of the mGluR5 antagonist fenobam is reported. Fenobam ( 1) was developed by McNeil Laboratories as an anxiolytic agent with an unknown molecular target in the late 1970s. In a recent publication, it was revealed that fenobam is a non-competitive mGluR5 antagonist. Herein, we present the structure–activity relationship of fenobam and its analogues and similarities between the SAR of mGluR5 antagonism and the SAR of CNS properties originally reported by McNeil are discussed.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2005.11.092